Cannabis-Derived Sativex for MS-Related Spasticity Reported to Be Effective and Safe
Barcelona, Spain-based, global pharma firm Almirall presented new clinical evidence at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) ā held in Barcelona October 7ā10, 2015 ā supporting the efficacy of its Sativex product, currently the only pharmaceutical medicine derived from cannabinoids…